echemi logo
Product
  • Product
  • Supplier
  • Inquiry
    Home > Active Ingredient News > Immunology News > J Dermatolog Treat: Dupilumab can effectively improve the quality of life of patients with atopic dermatitis

    J Dermatolog Treat: Dupilumab can effectively improve the quality of life of patients with atopic dermatitis

    • Last Update: 2021-05-20
    • Source: Internet
    • Author: User
    Search more information of high quality chemicals, good prices and reliable suppliers, visit www.echemi.com

    Atopic dermatitis (AD) severely affects the patient's quality of life (QoL).


    The researchers analyzed the aggregated data of two phase 3 studies of the same design, LIBERTY AD SOLO 1 (NCT02277743) and SOLO 2 (NCT02277769), and assessed the following PROs: Numerical Rating Scale for Pruritus (NRS), Pruritus Classification Scale, SCORing AD (SCORAD), Dermatological Quality of Life Index (DLQI), Patient-Oriented Eczema Measurement (POEM), Hospital Anxiety and Depression Scale (HADS), Five-Dimension European Quality of Life Questionnaire (EQ-5D), and patient assessment Disease conditions and treatment effects.


    The results showed that compared with placebo, dupilumab quickly improved the Peak Pruritus NRS score (p <.


     

    In summary, the results of the study show that Dupilumab significantly improves AD symptoms, including itching, sleep, pain, anxiety and depression, and QoL in adults with moderate to severe AD.


     

    Original source:

     

    Michael J Cork, et al.


    ncbi.
    nlm.
    nih.
    gov/31179791/" target="_blank" rel="noopener">Dupilumab improves patient-reported symptoms of atopic dermatitis, symptoms of anxiety and depression, and health-related quality of life in moderate-to-severe atopic dermatitis: analysis of pooled data from the randomized trials SOLO 1 and SOLO 2

    in this message
    This article is an English version of an article which is originally in the Chinese language on echemi.com and is provided for information purposes only. This website makes no representation or warranty of any kind, either expressed or implied, as to the accuracy, completeness ownership or reliability of the article or any translations thereof. If you have any concerns or complaints relating to the article, please send an email, providing a detailed description of the concern or complaint, to service@echemi.com. A staff member will contact you within 5 working days. Once verified, infringing content will be removed immediately.

    Contact Us

    The source of this page with content of products and services is from Internet, which doesn't represent ECHEMI's opinion. If you have any queries, please write to service@echemi.com. It will be replied within 5 days.

    Moreover, if you find any instances of plagiarism from the page, please send email to service@echemi.com with relevant evidence.